Karin Schelch

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

Journal: Diagnostics (Basel, Switzerland)
Published: March 03, 2026

Immune-related markers define clinically relevant prognostic subgroups in thymic epithelial tumors.

Immune-related markers define clinically relevant prognostic subgroups in thymic epithelial tumors.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 26, 2026

Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma.

Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma.

Journal: Antioxidants (Basel, Switzerland)
Published: November 07, 2025

Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments.

Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments.

Journal: Cancer research
Published: July 29, 2025

The micronucleus assay in exfoliated buccal cells for occupational exposure studies: an overview.

The micronucleus assay in exfoliated buccal cells for occupational exposure studies: an overview.

Journal: Mutagenesis
Published: May 08, 2025

The Micronucleus Assay in Exfoliated Buccal Cells for Occupational Exposure Studies: An Overview.

The Micronucleus Assay in Exfoliated Buccal Cells for Occupational Exposure Studies: An Overview.

Journal: Mutagenesis
Published: May 08, 2025

The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma.

The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma.

Journal: Cancers
Published: March 31, 2025

Small Particles, Big Problems: Polystyrene nanoparticles induce DNA damage, oxidative stress, migration, and mitogenic pathways predominantly in non-malignant lung cells.

Small Particles, Big Problems: Polystyrene nanoparticles induce DNA damage, oxidative stress, migration, and mitogenic pathways predominantly in non-malignant lung cells.

Journal: Journal of hazardous materials
Published: March 07, 2025

Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma.

Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma.

Journal: British journal of cancer
Published: March 04, 2025

Fibroblast growth factor signals drive the metastatic behavior in small cell lung cancer.

Fibroblast growth factor signals drive the metastatic behavior in small cell lung cancer.

Journal: British journal of cancer
Published: December 05, 2024

Impact of KRAS mutation subtypes on morphological heterogeneity and immune landscape in surgically treated lung adenocarcinoma.

Impact of KRAS mutation subtypes on morphological heterogeneity and immune landscape in surgically treated lung adenocarcinoma.

Journal: Translational lung cancer research
Published: November 15, 2024

Comparative profiling of surgically resected primary tumors and their lymph node metastases in small-cell lung cancer.

Comparative profiling of surgically resected primary tumors and their lymph node metastases in small-cell lung cancer.

Journal: ESMO open
Published: August 06, 2024
Showing 1-12 of 56

Last Updated: 09/26/2026